643
Views
0
CrossRef citations to date
0
Altmetric
Review

PSMA-targeted radioligand therapy in prostate cancer: current status and future prospects

&
Pages 959-975 | Received 02 Feb 2023, Accepted 09 Aug 2023, Published online: 28 Aug 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.